Patrick Verheyen
Direktor/Vorstandsmitglied bei CUE BIOPHARMA, INC.
Vermögen: 13 324 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Patrick Verheyen
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.
21
| Non-Profit Organization | Miscellaneous Commercial Services | 21 |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA.
16
| Extinct | Pharmaceuticals: Major | 16 |
| Public Company | Biotechnology | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Patrick Verheyen
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Director of Finance/CFO Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| University of London | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman Founder | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Stevenage Bioscience Catalyst
 Stevenage Bioscience Catalyst BiotechnologyHealth Technology Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. The company is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
| Trinity College, Cambridge | College/University | Undergraduate Degree Doctorate Degree | |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Pharmaceuticals: Major | Founder Founder | |
| AMBRX INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Bridge Valley Ventures LLP
 Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures LLP is a Venture Capital firm founded in 2017. Bridge Valley Ventures LLP is headquartered in Cambridge. | Investment Managers | Private Equity Investor Private Equity Investor | |
Intermediate Capital Group Plc (Private Equity)
 Intermediate Capital Group Plc (Private Equity) Investment ManagersFinance Intermediate Capital Group Plc (Private Equity) (ICG) is a private equity division of Intermediate Capital Group Plc founded in 1989. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Analyst | |
ProPharma Partners Ltd.
 ProPharma Partners Ltd. Miscellaneous Commercial ServicesCommercial Services ProPharma Partners Ltd. provides pharmaceutical and biotechnological consulting services. It helps its clients to develop and implement their strategic, business development, and clinical plans. The company is headquartered in Crawley, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member General Counsel | |
| Boston University | College/University | Undergraduate Degree Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Stabilitech Ltd.
 Stabilitech Ltd. BiotechnologyHealth Technology Stabilitech Ltd. develops technologies for the stabilization of biological molecules, such as vaccines and bio-pharmaceuticals. | Biotechnology | Corporate Officer/Principal Chief Operating Officer | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Comptroller/Controller/Auditor | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Washington University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Imperial College London | College/University | Graduate Degree Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer | |
| Viewpoint (US) | Director/Board Member | ||
DJS Antibodies Ltd.
 DJS Antibodies Ltd. BiotechnologyHealth Technology DJS Antibodies Ltd. designs and discovers novel therapeutic monoclonal antibodies against G-protein-coupled receptors. The firm conducts discovery against three targets in the fields of oncology, fibrosis and vascular disease. The company was founded by David Colin Conway Llewellyn and Joseph James Illingworth and is headquartered in Bicester, the United Kingdom. | Biotechnology | Director/Board Member | |
| PERSPECTIVE THERAPEUTICS, INC. | Medical Specialties | Director/Board Member | |
Lifearc Ventures
 Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Miscellaneous Commercial Services | Director/Board Member | |
Miles, Inc.
 Miles, Inc. Chemicals: Major DiversifiedProcess Industries Part of Bayer AG, Miles, Inc. is a chemical company. The company is based in Pittsburgh, PA. | Chemicals: Major Diversified | Corporate Officer/Principal | |
| The Catholic University of America | College/University | Graduate Degree | |
| MORPHOSYS AG | Biotechnology | Director/Board Member | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 26 |
| Vereinigtes Königreich | 17 |
| Japan | 3 |
| Israel | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 5 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 254 |
| Corporate Officer/Principal | 138 |
| Independent Dir/Board Member | 53 |
| Chairman | 51 |
| Chief Executive Officer | 40 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Arie Belldegrun | 42 |
| Tamar Howson | 41 |
| Samuel Saks | 28 |
| Samuel Cameron Williams | 27 |
| Peter Kiener | 25 |
| Fred Driscoll | 21 |
| Frank Morich | 21 |
| Russell Ellison | 20 |
| Allan P. Marchington | 19 |
| Peter J. Cozens | 19 |
| Thomas Malley | 17 |
| James Brown | 16 |
| Ruth McKernan | 16 |
| William F. Daly | 15 |
| David Atkins | 15 |
- Börse
- Insiders
- Patrick Verheyen
- Unternehmensverbindungen
